Anixa Biosciences, Inc. (FRA:CY71)
3.160
-0.940 (-22.93%)
At close: Dec 12, 2025
Anixa Biosciences Market Cap
Anixa Biosciences has a market cap or net worth of €92.7 million as of December 22, 2025. Its market cap has decreased by -6.37% in one year.
Market Cap
92.70M
Enterprise Value
78.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.16
Market Cap Chart
Since May 15, 1984, Anixa Biosciences's market cap has decreased from 100.76M to 92.70M, a decrease of -8.00%. That is a compound annual growth rate of -0.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 92.70M | 28.55% |
| Dec 31, 2024 | 72.11M | -33.88% |
| Dec 29, 2023 | 109.06M | -10.55% |
| Dec 30, 2022 | 121.93M | 55.90% |
| Dec 31, 2021 | 78.21M | 31.00% |
| Dec 31, 2020 | 59.70M | 1.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |